An RNA Interference Screen Identifies Metabolic Regulators NR1D1 and PBP as Novel Survival Factors for Breast Cancer Cells With the ERBB2 Signature

Cancer Research - United States
doi 10.1158/0008-5472.can-09-1550
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

An RNA Interference Screen Identifies New Avenues for Nephroprotection

Cell Death and Differentiation
Cell BiologyMolecular Biology
2015English

332 a Noncoding RNA CRISPR-interference Screen Identifies Novel Regulators and Pathways of Human Epidermis Formation

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

An Integrated Genomic Screen Identifies LDHB as an Essential Gene for Triple-Negative Breast Cancer

Cancer Research
Cancer ResearchOncology
2012English

RNA Chimeras as a Gene Signature of Breast Cancer

2014English

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells

2000English

An RNA Interference-Based Screen Identifies MAP4K4/NIK as a Negative Regulator of PPAR , Adipogenesis, and Insulin-Responsive Hexose Transport

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2006English

Novel Peptide/Protein Delivery System Targeting erbB2-Overexpressing Breast Cancer Cells

2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy